These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25886495)

  • 1. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
    He W; Zeng Q; Zheng Y; Chen M; Shen J; Qiu J; Chen M; Zou R; Liao Y; Li Q; Wu X; Li B; Yuan Y
    BMC Cancer; 2015 Apr; 15():263. PubMed ID: 25886495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.
    Zhong JH; Li H; Xiao N; Ye XP; Ke Y; Wang YY; Ma L; Chen J; You XM; Zhang ZY; Lu SD; Li LQ
    PLoS One; 2014; 9(9):e108755. PubMed ID: 25268959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.
    Qiu J; Zheng Y; Shen J; Zeng QA; Zou R; Liao Y; He W; Li Q; Chen G; Li B; Yuan Y
    Surgery; 2015 Nov; 158(5):1235-43. PubMed ID: 25958066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
    Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
    Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Choi SB; Kim HJ; Song TJ; Ahn HS; Choi SY
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):639-47. PubMed ID: 24867654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma.
    Choi GH; Park JY; Hwang HK; Kim DH; Kang CM; Choi JS; Park YN; Kim DY; Ahn SH; Han KH; Chon CY; Lee WJ
    Liver Int; 2011 Apr; 31(4):485-93. PubMed ID: 21382158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is portal hypertension a contraindication to hepatic resection?
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
    Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
    Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
    World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
    Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
    Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: a meta-analysis.
    Tang YH; Zhu WJ; Wen TF
    Asian Pac J Cancer Prev; 2014; 15(4):1649-54. PubMed ID: 24641383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
    Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
    Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma].
    An M; Park JW; Shin JA; Choi JI; Kim TH; Kim SH; Lee WJ; Park SJ; Hong EK; Kim CM
    Korean J Hepatol; 2006 Dec; 12(4):553-61. PubMed ID: 17237634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
    Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
    Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    He W; Li B; Zheng Y; Zou R; Shen J; Cheng D; Tao Q; Liu W; Li Q; Chen G; Yuan Y
    Liver Int; 2016 Nov; 36(11):1677-1687. PubMed ID: 27187721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic Liver Resection Is a Feasible Treatment for Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Harada N; Maeda T; Yoshizumi T; Ikeda T; Kayashima H; Ikegami T; Harimoto N; Takaki S; Maehara Y
    Anticancer Res; 2016 Jul; 36(7):3489-97. PubMed ID: 27354613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
    Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
    Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinically significant portal hypertension on surgical outcomes for hepatocellular carcinoma in patients with compensated liver cirrhosis: a propensity score matching analysis.
    Jang CW; Kwon HJ; Kong H; Ha H; Han YS; Chun JM; Kim SG; Hwang YJ
    Ann Hepatobiliary Pancreat Surg; 2016 Nov; 20(4):159-166. PubMed ID: 28261694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.